Transfer and Development of Mammalian Processes: Effective technology transfer for mammalian derived biopharmaceuticals ensuring process consistency and product quality

Translating innovations from research laboratories to clinical and commercial manufacturing is a complex process that requires effective technology transfer strategies. This webinar aims to provide a comprehensive overview of the critical aspects involved in technology transfer to support mammalian derived biopharmaceuticals. It will cover the following topics: - Technology transfer process overview: Exploring the key stages involved in the technology transfer process, from laboratory-scale to clinical and commercial manufacturing. - Identifying critical process controls: Assessing the critical process controls that need to be considered during technology transfer. - Risk management and mitigation strategies: Highlighting the potential risks and challenges faced during technology transfer and presenting strategies to mitigate them effectively. - Analytical methods and quality control: Discussing the analytical techniques and quality control measures required to demonstrate consistency, purity, and potency of the final product. - Regulatory considerations: Understanding the regulatory landscape and compliance requirements associated with technology transfer.

Author: Matthew Jones, Head of MSAT, Lonza